click below
click below
Normal Size Small Size show me how
pharmacology
respiratory, dermatologic, opthalmic, otic
| Question | Answer |
|---|---|
| what class is ipatropium | anticholinergic |
| what class is theophylline | methylxanthines |
| common long acting beta agonist (LABA) | salmeterol, formoterol |
| common short acting beta agonist (SABA) | albuterol, levalbuterol |
| what is the hallmark of asthma? | decreased forced expiatory volume |
| asthma remodeling results in what? | permanent structural changes |
| major characteristics of asthma | bronchial hyper-responsiveness airway inflammation airway obstruction |
| what is a contraindication to asthma corticosteroids? | hypersensitivity to mile products |
| first step in NAEPP guidelines in pharm. approach to asthma | SABA PRN |
| second step in NAEPP guidelines in pharm. approach to asthma | Low dose ICS |
| third step in NAEPP guidelines in pharm. approach to asthma | low dose ICS and LABA or medium dose ICS |
| fourth step in NAEPP guidelines in pharm. approach to asthma | Medium dose ICS and LABA |
| fifth step in NAEPP guidelines in pharm. approach to asthma | high dose ICS and LABA |
| sixth step in NAEPP guidelines in pharm. approach to asthma | high dose ICS and LABA and oral corticosteroid |
| LABA should NEVER be used without accompanying.... | corticosteriod |
| pathophysiology of COPD | chronic airflow limitation inflammation within airways, pulmonary vasculature and lung parenchyma |
| COPD changes include: | lung parynchemia decreased elastic recoil decreased force of expiration flattening of diaphragm |
| In a diagnosis of COPD what is the FEV1/FVC ? | <70% |
| In the COPD GOLD classification system, _____ and _____ automatically places the patient in stage IV: very severe catergory. | right sided heart failure and chronic respiratory failure |
| True of False: none of the medications used for COPD have been shown to modify long term lung function | True |
| what is prescribed for patients with group A in the COPD GOLD algorithm | SAMA or SABA |
| what is prescribed for patients with group B in the COPD GOLD algorithm | LAMA or LABA |
| what is prescribed for patients with group C in the COPD GOLD algorithm | ICS and LABA or LAMA |
| what is prescribed for patients with group D in the COPD GOLD algorithm | ICS and LABA and LAMA |
| What is the fist choice treatment plan for mild to moderate URI symptoms? | 1st choice is oral: antihistamine (non-sedating)& decongestant |
| what is the second choice for mild to moderate URI symptoms? | second choice is nasal: nasal antihistamines intranasal cromolyn & leukotriene receptor antagoinst |
| ointments | increased lubrication and occlusion use for dry or thick hyperkertotic lesion avoid in hairy areas |
| creams | mix of water and oil suspension well absorbed into the skin less potent than ointments no occlusive effects |
| lotions | less greasy and occlusive contains alcohol and has drying effect useful in hairy areas |
| gels | beneficial for exudative inflammation (poison ivy) dries quickly applied to scalp or hairy areas |
| with dermatologic agents topical antifungals, how long must you treat? | until complete turnover of skin |
| what is the hallmark of bacterial conjunctivitis? | purulent drainage |
| what is the hallmark of viral conjunctivitis? | clear drainage |
| Name a common LAMA | spiriva |
| name a common SAMA | atrovent |